EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

被引：0
|
作者：
Alexander J. J. Smits
J. Alain Kummer
John W. J. Hinrichs
Gerarda J. M. Herder
Karen C. Scheidel-Jacobse
N. Mehdi Jiwa
T. Emiel G. Ruijter
Peet T. G. A. Nooijen
Monica G. Looijen-Salamon
Marjolijn J. L. Ligtenberg
Frederik B. Thunnissen
Daniëlle A. M. Heideman
Roel A. de Weger
Aryan Vink
机构：
[1] St. Antonius Hospital,Department of Pathology
[2] University Medical Center Utrecht,Department of Pathology
[3] St. Antonius Hospital,Department of Pulmonary Diseases
[4] Medical Center Alkmaar,Department of Pathology
[5] Rijnstate Hospital,Department of Pathology
[6] Jeroen Bosch Hospital,Department of Pathology
[7] Radboud University Nijmegen Medical Centre,Department of Pathology
[8] VU University Medical Center,Department of Pathology
来源：
Cellular Oncology | 2012年 / 35卷
关键词：
Non-small cell lung cancer; Adenocarcinoma; Metastasis; Pleural effusion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：189 / 196
页数：7
相关论文
共 50 条
  • [41] EGFR and KRAS mutations in metastatic Lung adenocarcinomas
    Munfus-McCray, Delicia
    Harada, Shuko
    Adams, Christina
    Askin, Frederic
    Clark, Douglas
    Gabrielson, Edward
    Li, Qing Kay
    HUMAN PATHOLOGY, 2011, 42 (10) : 1447 - 1453
  • [42] Frequency of EGFR mutations in leptomeningeal metastasis of lung adenocarcinoma.
    Jiang, Ben-Yuan
    Yang, Jinji
    Su, Jian
    Chen, Zhihong
    Wu, Yi-Long
    Guo, Weibang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] FREQUENCY AND SPECTRUM OF EGFR MUTATIONS IN MOROCCAN LUNG ADENOCARCINOMA PATIENTS
    Elghissassi, I.
    Inrhaoun, H.
    Boukir, A.
    Bensouda, Y.
    Mrabti, H.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 432 - 432
  • [44] EGFR mutations in lung carcinomas: Mutation profile and survival analysis.
    Warrier, Narayanankutty Edavalath
    Vallathol, Dilip Harindran
    Sankar, Uma V.
    Salahuddin, Sameer
    Sreedharan, P. S.
    Parameswaran, Prasanth V.
    Sajeevan, K., V
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Relation of EGFR and KRAS mutation status with phosphorylation of EGFR in lung adenocarcinomas
    Brcic, L.
    Popper, H.
    VIRCHOWS ARCHIV, 2016, 469 : S327 - S327
  • [46] A CASE OF LUNG ADENOCARCINOMA WITH WILD-TYPE EGFR MALIGNANT PLEURAL EFFUSION WELL CONTROLLED BY TREATMENT WITH GEFITINIB
    Ueda, Y.
    Takahama, T.
    Sakai, K.
    Miyawaki, H.
    Yoshikawa, T.
    Misao, T.
    Aoe, M.
    Kanaji, N.
    Ishii, T.
    Bandoh, S.
    Matsunaga, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 146 - 146
  • [47] Concurrent EGFR and KRAS Mutations in Lung Adenocarcinoma: A Single Institution Case Series
    Schwartz, C.
    Khan, M.
    Nguyen, R.
    Pasquinelli, M.
    Feldman, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S600 - S601
  • [48] Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma
    Jiang, D.
    Wang, S.
    Huang, F.
    Zhang, X.
    Jin, H.
    Li, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1053 - S1054
  • [49] Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
    Planck, Maria
    Edlund, Karolina
    Botling, Johan
    Micke, Patrick
    Isaksson, Sofi
    Staaf, Johan
    PLOS ONE, 2013, 8 (10):
  • [50] Reversed Mutation Rates of KRAS and EGFR Genes in Adenocarcinoma of the Lung in Taiwan and Their Implications
    Wu, Chun-Chieh
    Hsu, Hui-Yu
    Liu, Hui-Ping
    Chang, John Wen-Cheng
    Chen, Ya-Ting
    Hsieh, Wen-Yu
    Hsieh, Jia-Juan
    Hsieh, Meng-Shu
    Chen, Yi-Rong
    Huang, Shiu-Feng
    CANCER, 2008, 113 (11) : 3199 - 3208
12345